[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

MX338911B - Identificacion mediada por trasposición de proteínas de unión o funcionales específicas. - Google Patents

Identificacion mediada por trasposición de proteínas de unión o funcionales específicas.

Info

Publication number
MX338911B
MX338911B MX2015000885A MX2015000885A MX338911B MX 338911 B MX338911 B MX 338911B MX 2015000885 A MX2015000885 A MX 2015000885A MX 2015000885 A MX2015000885 A MX 2015000885A MX 338911 B MX338911 B MX 338911B
Authority
MX
Mexico
Prior art keywords
binding
functional
fragments
host cells
expressed proteins
Prior art date
Application number
MX2015000885A
Other languages
English (en)
Other versions
MX2015000885A (es
Inventor
Ulf Grawunder
Original Assignee
Nbe Therapeutics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nbe Therapeutics Llc filed Critical Nbe Therapeutics Llc
Publication of MX2015000885A publication Critical patent/MX2015000885A/es
Publication of MX338911B publication Critical patent/MX338911B/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1055Protein x Protein interaction, e.g. two hybrid selection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1082Preparation or screening gene libraries by chromosomal integration of polynucleotide sequences, HR-, site-specific-recombination, transposons, viral vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10Cells modified by introduction of foreign genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241Nucleotidyltransferases (2.7.7)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/10Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14Specific host cells or culture conditions, e.g. components, pH or temperature
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55Fab or Fab'
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/60Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622Single chain antibody (scFv)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La presente invención se refiere a un método de tecnología novedosa que ofrece eficiencia no paralela, flexibilidad, utilidad y velocidad para el descubrimiento y optimización de polipéptidos que tienen especificidad y/o funcionalidad de unión deseada, que incluye moléculas de unión al antígeno tales como anticuerpos y fragmentos de los mismos, para los fenotipos funcionales y/o de unión deseados. El método novedoso se base en constructos de transposición y diversas bibliotecas de ADN clonadas en vectores de transposición y su transfección en células huésped por expresión temporal concomitante de una enzima de transposasa funcional. Esto asegura una introducción eficiente y estable de los vectores de expresión basados en transposón en células huésped de vertebrado en una etapa, que pueden clasificarse entonces por un fenotipo funcional o de unión deseado de las proteínas expresadas, después de lo cual las secuencias de codificación relevantes para las proteínas expresadas, que incluyen anticuerpos y fragmentos de los mismos, pueden identificarse por técnicas de clonación y secuenciación de ADN estándar.
MX2015000885A 2012-07-18 2013-07-18 Identificacion mediada por trasposición de proteínas de unión o funcionales específicas. MX338911B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261673144P 2012-07-18 2012-07-18
EP12178529.9A EP2692865B1 (en) 2012-07-30 2012-07-30 Transposition-mediated identification of specific binding or functional proteins
PCT/EP2013/065214 WO2014013026A1 (en) 2012-07-18 2013-07-18 Transposition-mediated identification of specific binding or functional proteins

Publications (2)

Publication Number Publication Date
MX2015000885A MX2015000885A (es) 2015-07-14
MX338911B true MX338911B (es) 2016-05-05

Family

ID=49775745

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015000885A MX338911B (es) 2012-07-18 2013-07-18 Identificacion mediada por trasposición de proteínas de unión o funcionales específicas.

Country Status (19)

Country Link
US (2) US10174309B2 (es)
EP (2) EP2692865B1 (es)
JP (1) JP6043431B2 (es)
CN (1) CN104640985B (es)
AU (1) AU2013291971B2 (es)
BR (1) BR112015000836B1 (es)
CA (1) CA2878982C (es)
DK (1) DK2692865T3 (es)
ES (1) ES2528892T3 (es)
HK (1) HK1209779A1 (es)
IL (1) IL236771A (es)
IN (1) IN2015DN01301A (es)
MX (1) MX338911B (es)
NZ (1) NZ705074A (es)
PT (1) PT2692865E (es)
SG (1) SG11201500280XA (es)
SI (1) SI2692865T1 (es)
WO (1) WO2014013026A1 (es)
ZA (1) ZA201500203B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201407852D0 (en) 2014-05-02 2014-06-18 Iontas Ltd Preparation of libraries od protein variants expressed in eukaryotic cells and use for selecting binding molecules
EP3368574A1 (en) 2015-10-30 2018-09-05 NBE-Therapeutics AG Anti-ror1 antibodies
CA3011815A1 (en) 2016-01-20 2017-07-27 The Scripps Research Institute Ror1 antibody compositions and related methods
SG11201806121PA (en) 2016-01-20 2018-08-30 Scripps Research Inst Ror2 antibody compositions and related methods
KR20180132705A (ko) * 2016-04-04 2018-12-12 에테하 취리히 단백질 생산 및 라이브러리(Library) 생성을 위한 포유동물 세포주
AU2017371179B2 (en) * 2016-12-09 2022-07-14 Gliknik Inc. Manufacturing optimization of GL-2045, a multimerizing stradomer
EP3551227A4 (en) 2016-12-09 2020-07-29 Gliknik Inc. METHOD FOR TREATING INFLAMMABLE DISEASES WITH MULTI-VALUE FC COMPOUNDS
JP7275043B2 (ja) 2016-12-16 2023-05-17 ビー-モーゲン・バイオテクノロジーズ,インコーポレーテッド 増大したhATファミリートランスポゾン媒介遺伝子導入ならびに関連する組成物、システムおよび方法
US11278570B2 (en) 2016-12-16 2022-03-22 B-Mogen Biotechnologies, Inc. Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods
US11447546B2 (en) 2017-07-20 2022-09-20 Nbe-Therapeutics Ag Human antibodies binding to ROR2
KR20230008269A (ko) 2017-08-07 2023-01-13 엔비이-테라퓨틱스 아게 생체 내 내성이 높은 항체 약물 결합체
US20210214747A1 (en) * 2018-05-18 2021-07-15 Sorbonne Universite Molecular tools and methods for transgene integration and their transposition dependent expression
WO2019246486A2 (en) 2018-06-21 2019-12-26 B-Mogen Biotechnologies, Inc. ENHANCED hAT FAMILY TRANSPOSON-MEDIATED GENE TRANSFER AND ASSOCIATED COMPOSITIONS, SYSTEMS, AND METHODS
SG11202103334YA (en) * 2018-10-26 2021-05-28 Hoffmann La Roche Multispecific antibody screening method using recombinase mediated cassette exchange
JP2020146014A (ja) * 2019-03-15 2020-09-17 株式会社東芝 トランスポゼース活性測定用ベクター、トランスポゼース活性測定用キット、トランスポゼース活性測定方法及び細胞分離方法
BR112022003970A2 (pt) 2019-09-03 2022-06-21 Myeloid Therapeutics Inc Métodos e composições para integração genômica
CN111139264B (zh) * 2020-01-20 2021-07-06 天津达济科技有限公司 一种基于线性双链dna分子在哺乳动物细胞系内构建单域抗体库的方法
CN111471714A (zh) * 2020-05-07 2020-07-31 西南大学 Minos转座子系统介导的真核生物转基因细胞系及构建方法
EP4271817A2 (en) 2020-12-30 2023-11-08 Alaunos Therapeutics, Inc. Recombinant vectors comprising polycistronic expression cassettes and methods of use thereof
JP2024507929A (ja) 2021-02-25 2024-02-21 アラウノス セラピューティクス インコーポレイテッド 多シストロン性発現カセットを含む組換えベクター及びそれらの使用方法
MX2023011638A (es) * 2021-03-31 2023-10-13 Ddbio Co Ltd Shang Hai Vectores y metodo para el cribado de proteinas de union a antigeno funcionales.
WO2023150562A1 (en) 2022-02-01 2023-08-10 Alaunos Therapeutics, Inc. Methods for activation and expansion of t cells
WO2024102954A1 (en) 2022-11-10 2024-05-16 Massachusetts Institute Of Technology Activation induced clipping system (aics)

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223409A (en) * 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5667988A (en) * 1992-01-27 1997-09-16 The Scripps Research Institute Methods for producing antibody libraries using universal or randomized immunoglobulin light chains
US6090382A (en) 1996-02-09 2000-07-18 Basf Aktiengesellschaft Human antibodies that bind human TNFα
US6218185B1 (en) 1996-04-19 2001-04-17 The United States Of America As Represented By The Secretary Of Agriculture Piggybac transposon-based genetic transformation system for insects
WO1998040510A1 (en) 1997-03-11 1998-09-17 Regents Of The University Of Minnesota Dna-based transposon system for the introduction of nucleic acid into dna of a cell
US7160682B2 (en) 1998-11-13 2007-01-09 Regents Of The University Of Minnesota Nucleic acid transfer vector for the introduction of nucleic acid into the DNA of a cell
US7105343B1 (en) 2000-10-31 2006-09-12 University Of Notre Dame Du Lac Methods and compositions for transposition using minimal segments of the eukaryotic transformation vector Piggybac
US6962810B2 (en) 2000-10-31 2005-11-08 University Of Notre Dame Du Lac Methods and compositions for transposition using minimal segments of the eukaryotic transformation vector piggyBac
HUP0400118A2 (hu) 2001-06-14 2005-02-28 Basf Corporation Fénystabilizáló gyököket tartalmazó fénystabilizált polimerek, ezekből készült cikkek és eljárás előállításukra
WO2003089618A2 (en) 2002-04-22 2003-10-30 Regents Of The University Of Minnesota Transposon system and methods of use
DE60319259T2 (de) * 2002-06-14 2009-03-05 Dyax Corp., Cambridge Rekombination von nukleinsäurebibliotheksmitgliedern
US20050182250A1 (en) 2002-07-10 2005-08-18 Stratagene Humanized renilla reniformis green fluorescent protein as a scaffold
EP1545613B9 (en) 2002-07-31 2012-01-25 Seattle Genetics, Inc. Auristatin conjugates and their use for treating cancer, an autoimmune disease or an infectious disease
US8071364B2 (en) * 2003-12-24 2011-12-06 Transgenrx, Inc. Gene therapy using transposon-based vectors
US7932088B1 (en) 2005-04-25 2011-04-26 University Of Notre Dame Du Lac High efficiency transformation of Plasmodium falciparum by the lepidopteran transposon, piggyBac
US20060252140A1 (en) 2005-04-29 2006-11-09 Yant Stephen R Development of a transposon system for site-specific DNA integration in mammalian cells
WO2007046439A1 (ja) * 2005-10-18 2007-04-26 National Institute Of Agrobiological Sciences 抗体を産生するトランスジェニックカイコとその製造方法
US20090042297A1 (en) * 2007-06-01 2009-02-12 George Jr Alfred L Piggybac transposon-based vectors and methods of nucleic acid integration
EP2160461B1 (en) 2007-07-04 2012-08-08 Max-Delbrück-Centrum für Molekulare Medizin (MDC) Hyperactive variants of the transposase protein of the transposon system sleeping beauty
CA2698727A1 (en) 2007-09-17 2009-03-26 Affomix Corporation Increasing specificity in a scfv screen using dual bait reporters
US7863425B2 (en) * 2007-09-26 2011-01-04 Cornell University Compositions and methods for inhibiting Yersinia pestis infection
AU2008311815B2 (en) 2007-10-19 2014-02-06 Seagen Inc. CD19 binding agents and uses thereof
CA2711806A1 (en) 2008-01-11 2009-07-16 Morphosys Ag Display vectors and methods and uses thereof
EP2244563B1 (en) * 2008-02-01 2019-08-28 Bogin, Robert Methods, compositions, and systems for production of recombinant spider silk polypeptides
JP2009225781A (ja) * 2008-02-29 2009-10-08 Neosilk Co Ltd カイコを用いた糖鎖構造に特徴を有する糖蛋白質の製造方法
EP2098536A1 (en) 2008-03-05 2009-09-09 4-Antibody AG Isolation and identification of antigen- or ligand-specific binding proteins
EP2379718B2 (en) * 2008-12-16 2020-12-30 Novartis AG Yeast display systems
US20100311116A1 (en) * 2009-06-04 2010-12-09 Excellgene Sa Fast generation of high expression stable cell lines expressing recombinant proteins under minimal and short-term selective pressure
BR112013014949B1 (pt) 2010-12-15 2021-12-28 Inter-University Research Institute Corporation Research Organization Of Information And Systems Métodos para a produção de uma proteína de interesse e para a obtenção de uma suspensão de células cho capaz de sobreviver e proliferar em um meio sem soro que produz uma proteína de interesse

Also Published As

Publication number Publication date
BR112015000836A2 (pt) 2017-12-12
AU2013291971A1 (en) 2015-02-05
CN104640985B (zh) 2021-05-11
US20150152406A1 (en) 2015-06-04
EP2692865A1 (en) 2014-02-05
CA2878982C (en) 2017-01-03
MX2015000885A (es) 2015-07-14
AU2013291971B2 (en) 2016-02-04
SI2692865T1 (sl) 2015-03-31
PT2692865E (pt) 2015-02-06
SG11201500280XA (en) 2015-02-27
JP6043431B2 (ja) 2016-12-14
WO2014013026A8 (en) 2014-12-04
DK2692865T3 (en) 2015-02-16
CN104640985A (zh) 2015-05-20
ZA201500203B (en) 2015-12-23
CA2878982A1 (en) 2014-01-23
ES2528892T3 (es) 2015-02-13
US20190153433A1 (en) 2019-05-23
IL236771A (en) 2016-09-29
EP2687599A1 (en) 2014-01-22
US10174309B2 (en) 2019-01-08
EP2692865B1 (en) 2014-12-10
WO2014013026A1 (en) 2014-01-23
JP2015522286A (ja) 2015-08-06
HK1209779A1 (en) 2016-04-08
BR112015000836B1 (pt) 2021-12-21
NZ705074A (en) 2017-04-28
IN2015DN01301A (es) 2015-07-03

Similar Documents

Publication Publication Date Title
MX338911B (es) Identificacion mediada por trasposición de proteínas de unión o funcionales específicas.
MX2019002498A (es) Metodos y productos para la expresion de proteinas en celulas.
MX2021000209A (es) Metodos y productos para transfeccion de celulas.
BR112014000627A2 (pt) polipepitídeo da polimerase mitante, proteína de fusão, moécula de ácido nucleico, vetor, processo de produção do vetor, célula hospedeira, método, composição, uso e kit
MX2013003681A (es) Ácidos nucleicos manipulados y métodos de uso de los mismos.
WO2013163263A3 (en) Methods for sorting nucleic acids and multiplexed preparative in vitro cloning
MX351850B (es) Metodo para el cribado de alfa-amilasas.
Carissimi et al. ARGONAUTE2 cooperates with SWI/SNF complex to determine nucleosome occupancy at human Transcription Start Sites
EP2695948A4 (en) METHOD AND KIT FOR SUPER-HIGH SENSITIVITY MEASUREMENT OF PROTEIN AND NUCLEIC ACID, AND NEW ENZYME SUBSTRATE
IL201395A (en) Multi-clonal cell lines and methods for generating multi-clonal cell lines
MX351565B (es) Colageno 7 y metodos relacionados.
WO2007003582A3 (en) Serum-free stable transfection and production of recombinant human proteins in human cell lines
MX2014007256A (es) Metodo rapido para la clonacion y expresion de segmentos genicos consanguineos de regiones variables de anticuerpos.
WO2013049121A3 (en) Recombinant phage and methods
NZ604019A (en) Methyltransferase nucleic acids and polypeptides
MX2014004598A (es) Variantes de alfa-amilasa y polinucleotidos que codifican las mismas.
EP3517611A3 (en) Methods for preparative in vitro cloning
EP4253534A3 (en) Alpha-amylase variants and polynucleotides encoding same
IL215014A (en) Unique antibody molecules link to human 13-il, preparations containing them, encoded DNA sequences, replication vectors and host cells, process for preparation and use thereof
WO2016161375A3 (en) Methods of using oligonucleotide-guided argonaute proteins
IN2014MN02500A (es)
EA201200186A1 (ru) Вектор, содержащий промотор маннозы, и промотор маннозы
WO2012164103A9 (en) Blockers of the nogo-a s1pr pathway for the treatment of diseases characterized by neuronal damage and lack of subsequent repair
IN2014CN00793A (es)
NZ590619A (en) High throughput screening method and use thereof to identify a production platform for a multifunctional binding protein

Legal Events

Date Code Title Description
FG Grant or registration